IRIS Accounts Production v23.3.1.45 06392161 director 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063921612022-12-31063921612023-12-31063921612023-01-012023-12-31063921612021-12-31063921612022-01-012022-12-31063921612022-12-3106392161ns10:Originalns15:EnglandWales2023-01-012023-12-3106392161ns14:PoundSterlingns10:Original2023-01-012023-12-3106392161ns10:Originalns10:Director12023-01-012023-12-3106392161ns10:Original2023-01-012023-12-3106392161ns10:Original2023-12-3106392161ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3106392161ns10:Originalns10:SmallEntities2023-01-012023-12-3106392161ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3106392161ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3106392161ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3106392161ns10:Originalns10:FullAccounts2023-01-012023-12-3106392161ns10:CompanySecretary1ns10:Original2023-01-012023-12-3106392161ns10:Originalns10:RegisteredOffice2023-01-012023-12-3106392161ns10:Original2022-12-3106392161ns10:Originalns5:CurrentFinancialInstruments2023-12-3106392161ns10:Originalns5:CurrentFinancialInstruments2022-12-3106392161ns5:ShareCapitalns10:Original2023-12-3106392161ns5:ShareCapitalns10:Original2022-12-3106392161ns10:Originalns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-3106392161ns10:Originalns5:FurtherSpecificReserve1ComponentTotalEquity2022-12-3106392161ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3106392161ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3106392161ns10:Original2022-01-012022-12-31
REGISTERED NUMBER: 06392161 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

INDOPHARMA LIMITED

INDOPHARMA LIMITED (REGISTERED NUMBER: 06392161)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


INDOPHARMA LIMITED

COMPANY INFORMATION
for the year ended 31 DECEMBER 2023







DIRECTOR: Y Patel





SECRETARY: J C Dave





REGISTERED OFFICE: First Floor Office Suite
240 Earls Court Road
London
SW5 9AA





REGISTERED NUMBER: 06392161 (England and Wales)





ACCOUNTANTS: Randall Robinson
Chartered Certified Accountants
Office 3.14
85 Gresham Street
London
EC2V 7NQ

INDOPHARMA LIMITED (REGISTERED NUMBER: 06392161)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Investments 4 433,000 433,000
Cash at bank 526 807
433,526 433,807
CREDITORS
Amounts falling due within one year 5 6,240 6,240
NET CURRENT ASSETS 427,286 427,567
TOTAL ASSETS LESS CURRENT
LIABILITIES

427,286

427,567

CAPITAL AND RESERVES
Called up share capital 25,000 25,000
Other reserves 431,895 431,895
Retained earnings (29,609 ) (29,328 )
SHAREHOLDERS' FUNDS 427,286 427,567

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

INDOPHARMA LIMITED (REGISTERED NUMBER: 06392161)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 February 2024 and were signed by:





Y Patel - Director


INDOPHARMA LIMITED (REGISTERED NUMBER: 06392161)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 DECEMBER 2023


1. STATUTORY INFORMATION

Indopharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. CURRENT ASSET INVESTMENTS
2023 2022
£    £   
Unlisted investments 433,000 433,000

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE
YEAR
2023 2022
£    £   
Other creditors 6,240 6,240